(3α,5β,E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic Acid(CAS: 1516887-33-4)

Regulatory guidelines for (3α,5β,E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic Acid (CAS: 1516887-33-4) include GHS classification, REACH regulations, FDA and EPA requirements. GHS categorizes this compound based on its potential hazards, while REACH requires documentation of its environmental and health impacts. FDA and EPA regulations focus on its use in pharmaceuticals and environmental releases, ensuring compliance with safety and environmental standards.

In synthesis, alternatives to (3α,5β,E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic Acid (CAS: 1516887-33-4) include isomers such as (3α,5α,E)-isomer and (3α,5β,Z)-isomer. Common alternative reagents include ethylidene acetate and other cholan derivatives. These alternatives offer similar structural and functional properties, making them viable substitutes in various chemical reactions.

The market for (3α,5β,E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic Acid (CAS: 1516887-33-4) is driven by emerging research in pharmaceuticals and dermatology. Recent trends indicate increased interest in its anti-inflammatory and antimicrobial properties. Market research suggests potential growth in demand for this compound, particularly in the development of topical treatments and advanced skincare products.

Waste containing (3α,5β,E)-6-Ethylidene-3-hydroxy-7-oxocholan-24-oic Acid (CAS: 1516887-33-4) should be collected in lined containers and stored in a cool, dry place away from sources of ignition. Incineration is a recommended method for disposal, ensuring it meets environmental protection standards. Alternatively, professional waste disposal services can manage larger quantities to ensure compliance with regulatory requirements and environmental safety.